Download Our Latest White Paper

BioLink is a specialty pharmaceutical company focused on the development and commercialization of patented treatments to meet the needs of underserved patient populations. 

BioLink builds on reformulations of “gold standards of care” to provide novel treatments eligible for approval using 505(b)(2) New Drug Applications.

BioLink Specifics

  • Focus on enhancement of standard of care treatments for chronic diseases

  • Pipeline depth & breadth: 5 drugs; multiple indications

  • Speed to market: 1 – 5 years

  • Minimal clinical risk: Established safety & efficacy

  • Limited development cost: < $10 million per drug for 505(b)(2) candidates

  • Experienced drug development team

BioLink Management Team

  • Dr. Deanna Nelson, President

  • Mr. Keith Satisky, General Counsel

BioLink Advisory Team

  • Ms. Nancy Chew, Regulatory Affairs North America

  • Dr. J. Mitchell Jones, Casimir Jones, Patent Attorneys

  • Mr. George Conbeer, Business Affairs (L,M&A)

  • Mr. John Spitznagel, Jr., Pharmaceutical Affairs

BioLink’s Research Collaborators

  • Dr. Chad Stahl, North Carolina State University

  • Dr. Jack Odle, North Carolina State University

  • Dr. Keith Hruska, Washington University, St. Louis

  • Dr. Dennis Miller, Cornell University

  • Dr. David Driscoll, UMass Medical School


About BioLink

BioLink is a specialty pharmaceutical company focused on the development and commercialization of patented treatments... Learn more here...

Learn More

Check out our informative resources:

Phosphate Binding Study

This study critically examines the efficacy of phosphate binding. Download our paper here...

Literature Review: Magnesium Inclusion in Phosphate Binding

What may be observed if calcium and magnesium are used in combination?

Download our paper here...

ASN Conference

If you missed us at ASN, you can still download our conference presentation material. 

Download here...

Partner With Us

At BioLink, we are always looking for terrific partners for our suite of products and patented molecules who can help us effectively reach appropriate patients and the clinicians who treat them. If you have an interest in Phosveda or any other BioLink assets, please reach out to us at info@phosveda.com or 919-678-9478.


Learn more here...